Bio-Thera Solutions, Ltd. (SHA:688177)
26.55
-0.54 (-1.99%)
At close: Oct 17, 2025
Bio-Thera Solutions Revenue
Bio-Thera Solutions had revenue of 235.33 million CNY in the quarter ending June 30, 2025, a decrease of -2.23%. This brings the company's revenue in the last twelve months to 782.77 million, down -1.22% year-over-year. In the year 2024, Bio-Thera Solutions had annual revenue of 743.17 million with 5.44% growth.
Revenue (ttm)
782.77M
Revenue Growth
-1.22%
P/S Ratio
14.04
Revenue / Employee
618.30K
Employees
1,251
Market Cap
10.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
Dec 31, 2020 | 182.86M | 182.16M | 26,023.37% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |